SEARCH RESULTS FOR: "Tag: ABBV"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2022(2)
2021(4)
2020(3)
2019(6)
2018(10)
2017(4)
2016(2)
2015(4)
2014(5)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(1)
Analyst Update(3)
Analyst Upgrades(1)
Bernie's Content(1)
Buzz Stocks(9)
By the Numbers(1)
Earnings Preview(1)
Editor's Pick(1)
Expectational Analysis(1)
General(6)
Indicator of the Week(1)
Intraday Option Activity(1)
Midday Market Check(2)
Opening View(4)
Quantitative Analysis(1)
Stocks On the Move(6)
Technical Analysis(2)
Trade Postmortem(1)
Unusual Trading Activity(1)

7/20/2022 1:00 AM
A growing dividend and expanding pipeline are two reasons to invest in ABBV stock AbbVie ( NYSE: ABBV ) is a conventional stock for unconventional times. And that’s exactly why it makes sense to a...
1/7/2022 10:23 AM
As we say welcome in the New Year with cautious optimism, it’s important to note not just the best stock picks to bet on, but also the ones to avoid. Historically, there are a notable amount of names ...
10/12/2021 3:04 PM
Last month was a doozy for investors. We've discussed how investors can manage September seasonality ad nauseam, but what about the other side of the coin? What stocks out there could fall victim to ...
10/1/2021 3:01 PM
If you're an investor, you're probably sick of the words 'September seasonality' by now. As the historically bearish period came to a close and ushered in a new month, all eyes were on Congress and ...
9/29/2021 10:02 AM
The U.S. Food and Drug Administration (FDA) just approved AbbVie Inc's (NYSE:ABBV) migraine prevention treatment, marking the company's third drug in its roster for severe headaches. The once-daily o...